Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome

Henson, 1995, College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors: Summary Members of the Cancer Committee, Arch Pathol Lab Med, 119, 1109

Allred, 1998, Prognostic and predictive factors in breast cancer by immunohistochemical analysis, Mod Pathol, 11, 155

Lockhart, 1996, Expression monitoring by hybridization to high-density oligonucleotide arrays, Nat Biotechnol, 14, 1675, 10.1038/nbt1296-1675

Chee, 1996, Accessing genetic information with high-density DNA arrays, Science, 274, 610, 10.1126/science.274.5287.610

Cheung, 1999, Making and reading microarrays, Nat Genet, 21, 15, 10.1038/4439

Sørlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with potential clinical implications, Proc Natl Acad Sci USA, 98, 10869, 10.1073/pnas.191367098

Bucher C, Torhorst J, Kononen J, Haas P, Schraml L, Bubendorf L, Zuber M, Kochli OR, Mross F, Dieterich H, Askaa J, Godtfredsen SE, Seelig S, Moch H, Mihatsch M, Kallioniemi O, Sauter G: Prognostic significance of HER-2 amplification and overexpression in breast cancer: methodological comparison of fluorescence in situ hybridization and immunohistochemistry using tissue microarrays of 611 primary breast cancers. J Pathol, in press

Torhorst, 2001, Tissue microarrays for rapid linking of molecular changes to clinical endpoints, Am J Pathol, 159, 2249, 10.1016/S0002-9440(10)63075-1

Elston, 1991, Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, 19, 403, 10.1111/j.1365-2559.1991.tb00229.x

Kononen, 1998, Tissue microarrays for high-throughput molecular profiling of tumor specimens, Nat Med, 4, 844, 10.1038/nm0798-844

Schraml, 1999, Tissue microarrays for gene amplification surveys in many different tumor types, Clin Cancer Res, 5, 1966

Natkunam, 2001, Analysis of MUM1/RF4-protein expression utilizing tissue microarrays and immunohistochemistry, Mod Pathol, 7, 686, 10.1038/modpathol.3880373

Cox, 1972, Regression models and life tables, J R Stat Soc, 74, 187

Hoch, 1999, GATA-3 is expressed in association with estrogen receptor in breast cancer, Int J Cancer, 84, 122, 10.1002/(SICI)1097-0215(19990420)84:2<122::AID-IJC5>3.0.CO;2-S

Perou, 2000, Molecular portraits of human breast tumors, Nature, 406, 747, 10.1038/35021093

Dairkee, 1987, Monoclonal marker that predicts early recurrence of breast cancer, Lancet, 1, 514, 10.1016/S0140-6736(87)92129-5

Malzahn, 1998, Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas, Virchows Arch, 433, 119, 10.1007/s004280050226